Alessandro Lupi

Showing 1-3 of 3 articles

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Coronary interventions

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Bongo A, Jaffe A

March 18, 2016 | 10.4244/EIJY14M11_04

Regarding “Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review”

Rognoni A, Santagostino M, Sansa M, Bongo A, Lupi A

September 28, 2012 | 10.4244/EIJV8I5A99

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Transcatheter mitral replacement after AVR

August 13, 2020

"Minimalist” TAVI during the COVID-19 pandemic: previously optional but now a necessity

August 13, 2020

Guidance Papers

Guidelines, consensus & position papers

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

IVUS for guidance of coronary interventions: applying optimisation targets to improve clinical outcomes

August 13, 2020

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease